Skip to main content
. Author manuscript; available in PMC: 2024 May 17.
Published in final edited form as: Glob Implement Res Appl. 2024 Apr 18;2024:10.1007/s43477-024-00119-5. doi: 10.1007/s43477-024-00119-5

Table 2.

Key Findings from Scoping Review of 94 Studies Applying an Implementation Facilitation Strategy

Implementation Facilitation (IF) Activity # of studies reporting use of activity (from 94 studies) % (rank, with top 5 bolded) # of studies identifying activity as ‘core’ (from 31 studies reporting ‘core’ activities) % (rank, with top 5 bolded) # of studies reporting use of the activity and positive implementation outcomesa % (rank, with top 5 bolded)b # of studies reporting use of the activity and positive process-of-care and/or patient outcomesa % (rank, with top 5 bolded)b
Conduct ongoing monitoring of program implementation 67 71% (1) 12 39% (3) 30/48 62.5 (13) 22/48 45.8 (10)
Clinical skills education 66 70% (2) 9 29% (6) 37/50 74.0 (4) 24/50 48.0 (4)
Engaging stakeholders, obtaining buy-in 63 67% (3) 19 61% (1) 31/46 67.4 (9) 22/46 47.8 (5)
Data collection to assess context and baseline performance 55 59% (4) 15 48% (2) 25/39 64.1 (11) 20/39 51.3 (2)
Providing updates and feedback 54 57% (5) 9 29% (6) 23/41 56.1 (14) 19/41 46.3 (9)
Technical support 54 57% (5) 11 35% (4) 27/40 67.5 (8) 20/40 50.0 (3)
Action / implementation planning 50 53% (6) 10 32% (5) 23/36 63.9 (12) 16/36 44.4 (11)
Providing support 49 52% (7) 15 48% (2) 26/38 68.4 (6) 18/38 47.4 (6)
Problem-solving 46 49% (8) 10 32% (5) 26/34 76.5 (2) 16/34 47.1 (7)
Adapting program to local context without compromising fidelity 41 44% (9) 7 23% (8) 20/27 74.1 (3) 9/27 33.3 (13)
Goal/priority setting 41 44% (9) 8 26% (7) 19/28 67.9 (7) 11/28 39.3 (12)
Managing group/team processes 40 43% (10) 8 26% (7) 21/30 70.0 (5) 14/30 46.7 (8)
Fostering change (unspecified) 39 41% (11) 4 13% (10) 17/26 65.4 (10) 13/26 50.0 (3)
Administrative tasks 34 36% (12) 9 29% (6) 20/25 80.0 (1) 13/25 52.0 (1)
Problem identification 33 35% (13) 7 23% (8) 17/23 73.9 13/23 56.5
Organizational change skills education 28 30% (14) 9 29% (6) 16/18 88.9 7/18 38.9
Fostering peer networking 26 28% (15) 4 13% (10) 17/21 81.0 9/21 42.9
Marketing 25 27% (16) 5 16% (9) 14/19 73.7 8/19 42.1
Fostering organizational change: structural 21 22% (17) 3 10% (11) 11/16 68.8 6/16 37.5
Developing shared vision / consensus building 17 18% (18) 5 16% (9) 8/10 80.0 2/10 20.0
Interceding and liaising with others 17 18% (18) 3 10% (11) 11/13 84.6 8/13 61.5
Identification / selection of local change agents 17 18% (18) 1 3% (13) 7/11 63.6 4/11 36.4
Describing / clarifying roles and responsibilities 15 16% (19) 3 10% (11) 7/12 58.3 7/12 58.3
Fostering networking with experts 14 15% (20) 4 13% (10) 6/8 75.0 2/8 25.0
Overcoming resistance to change 10 11% (21) 4 13% (10) 3/6 50.0 2/6 33.3
Fostering organizational change: cultural 9 10% (22) 0 4/4 100.0 1/4 25.0
Strategy/policy development 6 6% (23) 0 6/8 75.0 5/8 62.5
Pulling back and letting sites take lead 5 5% (24) 2 6% (12) 0/1 0/1
Attending, presenting at and/or organizing non-local meetings 3 3% (25) 0 3/3 100.0 0/3
Fostering spread of clinical innovation / facilitation methods 2 2% (26) 0 0/0 0/0
Helping to hire clinical program staff 2 2% (26) 0 2/2 100.0 1/2 50.0
Marketing education 1 1% (27) 0 0/1 0/1
a

For these columns, denominators are the number of studies that reported use of the activity AND reported outcomes. Examples of positive ‘implementation outcomes’ include items such as developing an action plan or implementation blueprint, establishing a patient registry, conducting a training, implementing a clinical reminder, developing patient education materials, etc. Examples of positive ‘process of care outcomes’ include improvements in prescribing, side effect monitoring, number of psychotherapy sessions, foot exams for people with diabetes, etc. Examples of positive ‘patient outcomes’ include improvements in symptoms, functioning, lab values, etc

b

For these columns, rankings are only provided for activities where denominator (number of studies) ≥ 25